Shoulder Innovations, Inc.

SI Healthcare Medical Devices

Shoulder Innovations, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $47.3 million, up 49.6% from fiscal 2024. In the quarter to June 2026, revenue grew 56.0%, EPS grew 99.7%, free cash flow fell 52.4% and total debt was flat, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.09 0.28 −1.52%
Market cap
$382.4M
P/E
0.0×
Fwd P/E
−8.4×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−2.42
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+5 more quarters

0.00 0.00 0.00 0.00
P/S ratio
4.23 2.62 5.57 7.00
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(19.96) (14.12) (24.28) (56.89)
P/B ratio
1.15 0.88 2.26 3.38
EV/Sales
1.20 0.31 3.83 5.60
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(1.65) (0.41) (4.72) (7.14)
Current Ratio
11.09 11.07 11.81 10.71
Net Debt/EBITDA
18.18 14.67 12.01 9.51
Debt/Equity
0.10 0.11 0.11 0.12
Earnings Yield
(2,283.65%) (1,529.23%) (1,149.07%) (9.47%)
Free Cash Flow Yield
(17.14%) (29.04%) (14.59%) (11.19%)
Free Cash Flow per Share
(0.84) (1.28) (0.73) (0.46)
Book value per Share
10.87 16.23 6.44 6.00
Free Cash Flow
(11.37) (11.06) (15.09) (9.55)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates